Clinical trial
Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
NCT00002504 · Hoag Memorial Hospital Presbyterian, Other · Completed
Key facts
| NCT number | NCT00002504 |
|---|---|
| Title | Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer |
| Official title | OUTPATIENT SUBCUTANEOUS IL-2 AND ALPHA INTERFERON IN THE MANAGEMENT OF METASTATIC CANCER |
| Lead sponsor | Hoag Memorial Hospital Presbyterian, Other |
| Collaborators | Cancer Biotherapy Research Group |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Chronic Myeloproliferative Disorders, Leukemia, Lymphoma, Multiple Myeloma and Plasma Cell Neoplasm, Myelodysplastic Syndromes, Precancerous/Nonmalignant Condition, Unspecified Adult Solid Tumor, Protocol Specific |
| Intervention type | Biological |
| Interventions | aldesleukin, recombinant interferon alfa |
| Start date | Aug 1, 1992 |
| Primary completion | Feb 1, 1998 |
| Completion | Feb 1, 1999 |
| First posted | Jul 26, 2004 |
| Last update posted | May 12, 2011 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: